Nicholas Papadopoulos
Medical Director
Cancer
Anderson Cancer Center
China
Biography
Papadopoulos retired as professor of medicine from the department of Melanoma Medical Oncology in 2014. He was specially challenged in taking care of patients with CNS disease and particularly those with leptomeningeal disease. A significant part of his 37 years practice at MD Anderson Cancer Center was also involved in the care of patients with the diagnosis of sarcoma. Papadopoulos has seen the evolution of systemic treatment from one chemotherapeutic agent to multiple drugs in combination with immunotherapy, and more recently the development of targeted therapy and immune check point agents a long lasting expectation. Papadopoulos is an advocate of the multidisciplinary approach in treating oncological patients where questions are addressed prior to initiating treatment. He has participated in multiple institutional committees through which many initiatives were examined. His experience in clinical oncology and functional organization is a tool in his current role in quality improvement process and concordance studies.
Research Interest
Cancer